AplusA ensures you are up-to-date with the latest vaccine market developments.
Over 30 years, AplusA has acquired a vast experience conducting market research on the topic of vaccination around the world, with both healthcare professionals and the target populations.
For example, each year we survey over 10,000 patients in the field of flu.
We are currently launching a new syndicated study in the field of RSV vaccination:
Discover AplusA's vaccine expertise presented by one of its experts, William MacGILLIVRAY 👇
Interested in becoming a founding partner of this new study? Contact our expert William MacGILLIVRAY (w.macgillivray@aplusaresearch.com) and discuss our solutions.
